Updates are available Correction dated 2022-01-07
Click to view Correction: https://doi.org/10.1038/s41592-022-01393-7
-
Authors
Stuart, Tim http://orcid.org/0000-0002-3044-0897
Srivastava, Avi
Madad, Shaista
Lareau, Caleb A.
Satija, Rahul http://orcid.org/0000-0001-9448-8833
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (K99HG011489-01, DP2HG009623-01)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OT2OD026673-01)
- License Information
-
More Information
Article History
Received: 17 November 2020
Accepted: 27 August 2021
First Online: 1 November 2021
Change Date: 7 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41592-022-01393-7
Competing interests
: In the past 3 years, R.S. has worked as a consultant for Bristol-Myers Squibb, Regeneron and Kallyope and served as an SAB member for ImmunAI, Resolve Biosciences, Nanostring, and the NYC Pandemic Response Lab. The remaining authors declare no competing interests.
